Study: The Bottom Line: The "Ozempic melts muscle" narrative is fear-mongering
Effect of DPP-4 inhibitor on elderly patients with T2DM combined with MCI
As more people become aware of these medications and the stigma associated with seeking treatment for obesity ebbs, this demand will continue to rise: Research from the University of Southern California showed a 442% increase in prescriptions for semaglutide between January 2021 and December 2023
CrossRef Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunctionassociated steatotic liver disease Rishi Chowdhary, Manjeet Kumar Goyal, Megh Patel, Rahul Chowdhary, Kirti Arora, Varun Mehta, Akash Batta, Omesh Goyal, Ashita Rukmini Vuthaluru Frontiers in Epidemiology .2026;[Epub] CrossRef Liver steatosis and fibrosis in acromegaly patients with active and controlled disease: a scoping review Karol P